Comment on

• Statistical analysis of randomized trials in tobacco treatment: longitudinal designs with dichotomous outcome.

  Hall SM, Delucchi KL, Velicer WF, Kahler CW, Ranger-Moore J, Hedeker D, Tsoh JY, Niaura R. Hall SM, et al. Nicotine Tob Res. 2001 Aug;3(3):193-202. doi: 10.1080/14622200110050411. Nicotine Tob Res. 2001. PMID: 11506764
• Biochemical verification of tobacco use and cessation.

  SRNT Subcommittee on Biochemical Verification. SRNT Subcommittee on Biochemical Verification. Nicotine Tob Res. 2002 May;4(2):149-59. doi: 10.1080/14622200210123581. Nicotine Tob Res. 2002. PMID: 12028847 No abstract available.
• Methodological issues in measuring treatment outcome in adolescent smoking cessation studies.

  Mermelstein R, Colby SM, Patten C, Prokhorov A, Brown R, Myers M, Adelman W, Hudmon K, McDonald P. Mermelstein R, et al. Nicotine Tob Res. 2002 Nov;4(4):395-403. doi: 10.1080/1462220021000018470. Nicotine Tob Res. 2002. PMID: 12521399
• Measures of abstinence in clinical trials: issues and recommendations.

  Hughes JR, Keely JP, Niaura RS, Ossip-Klein DJ, Richmond RL, Swan GE. Hughes JR, et al. Nicotine Tob Res. 2003 Feb;5(1):13-25. Nicotine Tob Res. 2003. PMID: 12745503
• Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials.

  Shiffman S, West R, Gilbert D; SRNT Work Group on the Assessment of Craving and Withdrawal in Clinical Trials. Shiffman S, et al. Nicotine Tob Res. 2004 Aug;6(4):599-614. doi: 10.1080/14622200410001734067. Nicotine Tob Res. 2004. PMID: 15370156 Review.